
Perimenopause Brain Fog, ADHD, and Mood Screening in Primary Care
Marlee Madora, MD, explains how primary care physicians can assess perimenopause brain fog, rule out ADHD, and screen for mood changes.
Perimenopause brain fog can lead patients to fear a neurodegenerative disease, but a careful assessment often points to treatable causes, according to Marlee Madora, MD, a reproductive psychiatrist at Montefiore Einstein.
"When you offer patients a diagnosis, you provide them with so much hope," Madora said.
Patients often describe losing words mid-presentation or forgetting why they walked into a room. Such changes are common in perimenopause. In the Study of Women's Health Across the Nation, which followed 2362 participants for 4 years, perimenopause was associated with a decline in learning that rebounded to premenopausal levels after menopause.¹ To evaluate perimenopause brain fog, Madora starts with the Montreal Cognitive Assessment and refers some patients for full neuropsychological testing, which can uncover ADHD that patients had compensated for until now.
Another misconception, she says, is "I'm still getting my period. There's no way I'm in perimenopause." Because the rate of hormonal change drives many emotional symptoms, ongoing periods are typical of perimenopause.
Beyond the PHQ-9 and GAD-7, Madora recommends that primary care physicians ask about mood changes across earlier reproductive transitions, including the premenstrual weeks, pregnancy and the postpartum period. Guidelines on perimenopausal depression likewise recommend asking about past reproductive mood symptoms.² Her favorite tool is the Menopause Rating Scale, which covers somatic, psychological and urogenital symptoms.³
She also urges physicians to ask about sexual health in a normalizing way, because patients rarely raise it themselves. Most of all, she says, clinicians should approach these visits with curiosity and validation rather than a checklist.
Watch the video to hear the language Madora uses to start these conversations with patients.
Patient Care Online: What are some common misconceptions patients have about menopause and mental health?
Madora: The most common misconception is, "I am still getting my period, so there is no way I am in perimenopause." But when someone is still getting their period, that is exactly when they are in perimenopause. Menopause is when periods have stopped completely. It is the rate of hormonal change that drives many of these emotional symptoms, and that happens while patients are still menstruating.
Another common misconception involves cognitive symptoms like brain fog and forgetfulness. Patients may worry that they have a chronic, debilitating neurodegenerative disorder. When you look more closely, it often looks more like perimenopausal cognitive change. Verbal recall declines and word-finding gets harder during this period. Women might say, "I could not think of the word I needed during that presentation," or, "I went to the kitchen and did not know what I was looking for." That can be really distressing.
I like to do a comprehensive assessment. I often start with the Montreal Cognitive Assessment (MoCA), which does a good job of looking at verbal memory. When needed, I refer patients for a full neuropsychological assessment. You can also consider whether the patient may have attention-deficit/hyperactivity disorder (ADHD). Maybe they have had ADHD their whole life and compensated until now, when they are dealing with more emotional strain, sleep difficulties, more demands, and the cognitive changes that are common in perimenopause.
Offering patients a diagnosis gives them so much hope. They need to know there are treatments that work for these cognitive symptoms, such as cognitive behavioral therapy for ADHD, nonstimulant medications, and stimulant medications. This can be life-changing for patients who are anxious about their cognitive symptoms.
PCO: How can clinicians better screen for mental health concerns during midlife transitions?
Madora: Screen for mood changes across reproductive transitions. Ask questions like, "When you were getting your period regularly, were there times right before your period when you felt more anxious, depressed, or irritable, to the point that other people noticed?" Ask, "How was pregnancy for you? How was the postpartum period?" Ask about the menstrual cycle and any changes they are noticing now, and about urogenital changes.
Ask about sex, too. It is hard to ask patients about their sex lives, but if you do not, they are not going to bring it up. Ask in a normalizing way, for example: "A lot of women notice that hormone changes can really affect their sex lives. Is that happening to you?" Patients need to hear that they have a place to talk about it, because it affects their self-esteem and relationships, and addressing it can really improve how they feel about themselves.
My favorite tool during perimenopause is the Menopause Rating Scale. It covers 3 domains: somatic, psychological, and urogenital symptoms. It captures the full range of perimenopausal symptoms, so you know where to focus treatment.
PCO: What practical advice do you have for clinicians discussing emotional health with patients in menopause?
Madora: The most important thing is to help your patients feel comfortable talking about it. Validate that this can be an emotionally difficult time, that these hormone changes are really challenging, and that there is hope. Ask how their hormones are affecting their sleep, mood, urogenital symptoms, and sex lives. Come at it with curiosity rather than just labeling the patient as perimenopausal and prescribing X, Y, and Z. Really try to hear their particular story, so they feel like you are a partner in this at a time when many women feel alone
References
- Greendale GA, Huang MH, Wight RG, et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology. 2009;72(21):1850-1857. doi:10.1212/WNL.0b013e3181a71193
- Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. J Womens Health (Larchmt). 2019;28(2):117-134. doi:10.1089/jwh.2018.27099.mensocrec
- Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes. 2004;2:45. doi:10.1186/1477-7525-2-45
Related to this article








